Boston Medical Center (BMC) Grayken Center for Addiction Training and Technical Assistance (TTA)

A Resource for Healthcare and Social Services Professionals

Experience & Evidence: Understanding Opioid-Related Evidence-Based Practices

Estimated time to complete: 1 hour 30 minutes

This activity reviews the HEALing Communities Study Evidence-Based Practices of naloxone, medications for opioid use disorder, and prescription opioid safety.


Register now

Description

This activity reviews the HEALing Communities Study Evidence-Based Practices of naloxone, medications for opioid use disorder, and prescription opioid safety. In addition to brief evidence summaries, experienced health care professionals provide their perspective on and advice for implementing the practices to reduce opioid overdose deaths in highly affected communities.

Intended audience

Physicians, physician assistants, nurses, pharmacists, pharmacy techs and other interested health care professionals practicing in the following HEALing Communities Study Wave 1 communities:

Speakers

---- ----

Alexander Walley, MD, MSc, CME Course Director

Ilana Hardesty, MA, Planning Committee

David Morgan, RPH, Planning Committee

Trish Freeman, RPh, PhD, FAPhA, FNAP, Planning Committee

Conor Monks, Planning Committee

Members of the planning committee have no relevant financial relationships to disclose.

Phuong Huynh, MD

Faculty is Vice Chair of the Board of Directors at Ohio Physician Health Program and is a contracted physician reviewer for the Medical Review Institute of America. Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product.”

Laila Khalid, M.B.B.S., M.P.H.

Faculty member has no relevant financial relationships to disclose. Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product.

Alyssa M. Peckham PharmD, BCPP

Faculty is employed by Otsuka Pharmaceutical Companies as a Neuroscience Medical Science Liaison. Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product.

Monica Roberts, PharmD

Faculty member has no relevant financial relationships to disclose. Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product.

Barry Rose, BSPharm, Recovery Coach

Faculty member has no relevant financial relationships to disclose. Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product.”

Objectives

Upon conclusion of this CE activity, participants should be able to:

Sponsored by

HEALing Communities Study

Accreditation information

Pharmacy Accreditiation Information

Topic Designator: Disease State Management/Drug Therapy

Activity Type: Knowledge-based

Expires 12/15/2023

Pharmacist | UAN 0026-9999-21-085-H04-P

Pharmacy Technician | 0026-9999-21-085-H04-T

Accreditation

Massachusetts College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Massachusetts College of Pharmacy and Health Sciences designates this educational activity for a total of 1.5 contact hours (0.15 CEUs).

Requirements for Credit

Credit will not be issued to participants who do not complete the pre-test, post-test and evaluation. Credit may take up to 30 days to reflect on the CPE Monitor profile for the participants.

Statement of Disclosure

Massachusetts College of Pharmacy and Health Sciences adheres to the ACPE Standards for Integrity and Independence in Continuing Education.  It is the policy of MCPHS University that the speakers and planning committee members disclose all financial relationships with ineligible companies, and that relevant conflicts of interest are mitigated.  Speakers will disclose any unlabeled/unapproved use of drugs or devices during their presentation.

Alyssa M. Peckham is employed by Otsuka Pharmaceutical Companies as a Neuroscience Medical Science Liaison.

Barry Rose holds no relevant financial relationship with ineligible companies.

Laila Khalid holds no relevant financial relationship with ineligible companies.

Phuong Huynh is Vice Chair of the Board of Directors at Ohio Physician Health Program and is a contracted physician reviewer for the Medical Review Institute of America.

All MCPHS CE staff members have no relevant financial relationships with ineligible companies to disclose.

 

CME Accreditation Information

ACCME Accreditation Statement

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Boston University School of Medicine designates this enduring activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Date of Release: 3/18/2022 

Date of Expiration: 12/31/2023

Boston University School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed. 

In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships with ineligible companies that faculty, planners, authors and anyone who may be in control of content have been mitigated.

THIS CONTINUING MEDICAL EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.  NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.

This program meets the criteria of the Kentucky Board of Medical Licensure for HB1 Credit.  Approval ID 0422-H1.5-UKHC1e.

Register now

Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.

Funding for Grayken Center for Addiction TTA is provided by:

Massachusetts Department of Public Health Bureau of Substance Abuse Services (BSAS)
GE Foundation
Opioid Response Network

© 2022 Boston Medical Center. All rights reserved. Site by Signal.